- Home
- BNGO vs CRIS Comparison
BNGO vs CRIS Comparison
Compare BNGO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- CRIS
- Stock Information
- Founded
- BNGO 2003
- CRIS 2000
- Country
- BNGO United States
- CRIS United States
- Employees
- BNGO N/A
- CRIS N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BNGO Industrials
- CRIS Health Care
- Exchange
- BNGO Nasdaq
- CRIS Nasdaq
- Market Cap
- BNGO 24.3M
- CRIS 21.3M
- IPO Year
- BNGO 2018
- CRIS 2000
- Fundamental
- Price
- BNGO $3.38
- CRIS $1.80
- Analyst Decision
- BNGO Buy
- CRIS Strong Buy
- Analyst Count
- BNGO 5
- CRIS 2
- Target Price
- BNGO $7.33
- CRIS $16.50
- AVG Volume (30 Days)
- BNGO 85.5K
- CRIS 179.9K
- Earning Date
- BNGO 08-06-2025
- CRIS 07-31-2025
- Dividend Yield
- BNGO N/A
- CRIS N/A
- EPS Growth
- BNGO N/A
- CRIS N/A
- EPS
- BNGO N/A
- CRIS N/A
- Revenue
- BNGO $28,464,000.00
- CRIS $11,202,000.00
- Revenue This Year
- BNGO N/A
- CRIS N/A
- Revenue Next Year
- BNGO $15.54
- CRIS $10.67
- P/E Ratio
- BNGO N/A
- CRIS N/A
- Revenue Growth
- BNGO N/A
- CRIS 14.17
- 52 Week Low
- BNGO $2.68
- CRIS $1.02
- 52 Week High
- BNGO $41.10
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- BNGO 45.80
- CRIS 42.69
- Support Level
- BNGO $3.31
- CRIS $1.70
- Resistance Level
- BNGO $3.43
- CRIS $2.01
- Average True Range (ATR)
- BNGO 0.14
- CRIS 0.21
- MACD
- BNGO 0.03
- CRIS -0.03
- Stochastic Oscillator
- BNGO 68.97
- CRIS 38.78
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.